The incidence of pulmonary fibrosis in World Trade Center responders is significantly increased and tracks with duration of exposure. Current therapy options are limited and have not been demonstrated to increase life expectancy. We plan to test an exciting lead compound in World Trade Center relevant models of pulmonary fibrosis.
No publications available at this time.
